Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of cardiac fibrosis is the largest unmet medical need in heart failure
Javier Dı́ez, Rudolf A. de Boer
Cardiovascular Research (2021) Vol. 118, Iss. 2, pp. e20-e22
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Growing Heart Failure Burden of Hypertensive Heart Disease: A Call to Action
Javier Dı́ez, Javed Butler
Hypertension (2022) Vol. 80, Iss. 1, pp. 13-21
Closed Access | Times Cited: 39
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Susana Ravassa, Begoña López, Thomas A. Treibel, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101194-101194
Open Access | Times Cited: 38
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
Hao Zhang, Phung N. Thai, Rabindra V. Shivnaraine, et al.
Cell (2024)
Closed Access | Times Cited: 11
Pleiotropic effects of SGLT2 inhibitors and heart failure outcomes
Panagiotis Theofilis, Μarios Sagris, Evangelos Oikonomou, et al.
Diabetes Research and Clinical Practice (2022) Vol. 188, pp. 109927-109927
Closed Access | Times Cited: 30
Large animal models of pressure overload-induced cardiac left ventricular hypertrophy to study remodelling of the human heart with aortic stenosis
Evangelia Beslika, Adelino Leite‐Moreira, León J. De Windt, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 5, pp. 461-475
Open Access | Times Cited: 7
Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence
Lipeng Shi, Jingwei Deng, Jun He, et al.
European Journal of Pharmacology (2024) Vol. 975, pp. 176632-176632
Open Access | Times Cited: 7
Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
Ida G. Lunde, Karoline Bjarnesdatter Rypdal, Sophie Van Linthout, et al.
Matrix Biology (2024) Vol. 134, pp. 1-22
Closed Access | Times Cited: 7
Nuclear ATP-citrate lyase regulates chromatin-dependent activation and maintenance of the myofibroblast gene program
Michael P. Lazaropoulos, Andrew Gibb, Douglas J. Chapski, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 7, pp. 869-882
Open Access | Times Cited: 6
Salvianolic acid A diminishes LDHA‐driven aerobic glycolysis to restrain myofibroblasts activation and cardiac fibrosis via blocking Akt/GSK‐3β/HIF‐1α axis
Renaguli Hailiwu, Hao Zeng, Meiling Zhan, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 10, pp. 4540-4556
Closed Access | Times Cited: 15
Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies FIXER , a Conserved Profibrogenic Long Noncoding RNA
Parisa Aghagolzadeh, Isabelle Plaisance, Riccardo Bernasconi, et al.
Circulation (2023) Vol. 148, Iss. 9, pp. 778-797
Open Access | Times Cited: 15
Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
Maria Vistnes
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 267-267
Open Access | Times Cited: 5
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Maria Vistnes, Pugazendhi M Erusappan, Athiramol Sasi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 10, pp. 1915-1927
Open Access | Times Cited: 12
Fibulin 1 and 2 Levels in Patients with Heart Failure: Comparison of Different Heart Failure Stages and Exploring the Temporal Changes During Acute Exacerbation
Burcu Cihan, Emrullah Kızıltunç, Canan Yılmaz, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access
AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine
Changxing Liu, Xinyi Guo, Yabin Zhou, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5451-5464
Open Access | Times Cited: 10
Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment
Karoline Bjarnesdatter Rypdal, Suneel Apte, Ida G. Lunde
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 3
Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
Lipeng Shi, Xuqin Du, Biao Zuo, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 13
Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
Athiramol Sasi, Andreas Romaine, Pugazendhi M Erusappan, et al.
Matrix Biology Plus (2023) Vol. 19-20, pp. 100135-100135
Open Access | Times Cited: 7
A New Ex Vivo Model to Study Cardiac Fibrosis in Whole Mouse Hearts
Boudewijn P. T. Kruithof, Babak Mousavi Gourabi, Arjanneke F. van de Merbel, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 8, pp. 1005-1022
Open Access | Times Cited: 2
miR-409-3p Regulated by GATA2 Promotes Cardiac Fibrosis through Targeting Gpd1
Chun Wang, Shengxia Yin, Qin Wang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 11
Tumor Growth Ameliorates Cardiac Dysfunction
Lama Awwad, Rona Shofti, Tali Haas, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1853-1853
Open Access | Times Cited: 5
Tumor Growth Ameliorates Cardiac Dysfunction and Suppresses Fibrosis in a Mouse Model for Duchenne Muscular Dystrophy
Laris Achlaug, Lama Awwad, Irina Langier Goncalves, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12595-12595
Open Access | Times Cited: 5
Tumor growth ameliorates cardiac dysfunction and dampens fibrosis in a mouse model for Duchenne Muscular Dystrophy
Laris Achlaug, Lama Awwad, Irina Langier Goncalves, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
Quantitative assessment of myocardial fibrosis by digital image analysis: An adjunctive tool for pathologist “ground truth”
João Abecasis, Nuno Cortez‐Dias, Daniel Pinto, et al.
Cardiovascular Pathology (2023) Vol. 65, pp. 107541-107541
Open Access | Times Cited: 4
Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?
Sebastian Neuber, Miriam R. Ermer, Maximilian Y. Emmert, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10480-10480
Open Access | Times Cited: 4
A Review of Therapeutic Strategies against Cardiac Fibrosis: From Classical Pharmacology to Novel Molecular, Epigenetic, and Biotechnological Approaches
Erica Floris, Claudia Cozzolino, Sangar Marconi, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 8
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top